|
2016 AUA Urologic Oncology Research Symposium: ""Forging New Paths in Research to Advance Urologic Oncology
|
1U13CA206383-01
|
$10,000
|
$3,300
|
BEST, CAROLYN
|
AMERICAN UROLOGICAL ASSOCIATION
|
|
Cancer-associated fibroblast in the regulation of bladder cancer stem cells
|
4R01CA175397-04
|
$324,738
|
$324,738
|
CHAN, KEITH SYSON
|
BAYLOR COLLEGE OF MEDICINE
|
|
ESTROGEN RECEPTOR TARGETED TREATMENT OF NON-MUSCLE INVASIVE BLADDER CANCER
|
4K23CA160664-04
|
$122,436
|
$122,436
|
GODOY, GUILHERME
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S1
|
$118,016
|
$2,360
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S2
|
$170,897
|
$3,418
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S3
|
$118,875
|
$2,378
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S4
|
$499,947
|
$9,999
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S5
|
$134,220
|
$2,684
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-10
|
$3,253,119
|
$65,062
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-03S1
|
$1,595,651
|
$31,913
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-03S2
|
$550,000
|
$11,000
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-03S3
|
$750,000
|
$15,000
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
5U10CA180821-03
|
$9,068,022
|
$181,360
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Molecular Pathogenesis of the Hamartoma Syndromes
|
4P01CA120964-10
|
$1,781,629
|
$213,795
|
KWIATKOWSKI, DAVID
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Analyzing Complex Cancer Studies With Skewed Responses
|
1R03CA205018-01
|
$102,674
|
$102,674
|
LIPSITZ, STUART
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
CWRU Case Comprehensive Cancer Center NCTN Lead Academic Participating Site
|
5U10CA180853-03
|
$1,033,213
|
$25,830
|
MACHTAY, MITCHELL
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Sh3gl2 and chemosensitivity of bladder cancer
|
1R21CA198722-01A1
|
$282,050
|
$282,050
|
ADAM, ROSALYN
|
CHILDREN'S HOSPITAL CORPORATION
|
|
Gender Difference in Bladder Cancer Susceptibility
|
5R21CA198544-02
|
$230,985
|
$230,985
|
LI, XUE
|
CHILDREN'S HOSPITAL CORPORATION
|
|
Investigating the cell of origin for bladder cancer
|
5R01CA193442-02
|
$474,774
|
$474,774
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-42S1
|
$120,000
|
$1,200
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-42S2
|
$60,000
|
$600
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-42S3
|
$121,873
|
$1,219
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-42S4
|
$150,866
|
$1,509
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-42S5
|
$199,541
|
$1,995
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-42S6
|
$500,000
|
$5,000
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
5P30CA013696-42
|
$3,792,720
|
$37,927
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
IGF::OT::IGF OPTION 1: CORE INFRASTRUCTURE SUPPORT FOR SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) POP: 05/01/2016 TO 04/30/2017
|
261201300019I
|
$2,837,071
|
$425,561
|
UNKNOWN, UNKNOWN
|
CONNECTICUT STATE DEPT OF PUBLIC HEALTH
|
|
Cancer Center Support Grant
|
3P30CA006516-51S1
|
$122,500
|
$1,225
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-51S2
|
$37,500
|
$375
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-51S3
|
$125,000
|
$1,250
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-51S4
|
$200,000
|
$2,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-51S5
|
$60,000
|
$600
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-51S6
|
$199,953
|
$2,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-51S7
|
$500,000
|
$5,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-51S8
|
$750,000
|
$7,500
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
4P30CA006516-51
|
$11,151,311
|
$111,513
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care
|
5U10CA180867-03
|
$1,106,869
|
$41,508
|
BURSTEIN, HAROLD
|
DANA-FARBER CANCER INST
|
|
Dartmouth Lead Participation in NCI National Clinical Trials Network
|
5U10CA180854-03
|
$375,850
|
$18,793
|
DRAGNEV, KONSTANTIN
|
DARTMOUTH COLLEGE
|
|
NCI National Clinical Trials Network U10
|
5U10CA180857-03
|
$392,946
|
$9,824
|
CRAWFORD, JEFFREY
|
DUKE UNIVERSITY
|
|
ECOG-ACRIN Operations Center
|
3U10CA180820-03S1
|
$757,854
|
$15,157
|
COMIS, ROBERT
|
ECOG-ACRIN MEDICAL RESEARCH FOUNDATION
|
|
ECOG-ACRIN Operations Center
|
3U10CA180820-03S2
|
$92,128
|
$1,843
|
COMIS, ROBERT
|
ECOG-ACRIN MEDICAL RESEARCH FOUNDATION
|
|
ECOG-ACRIN Operations Center
|
5U10CA180820-03
|
$12,481,775
|
$249,636
|
COMIS, ROBERT
|
ECOG-ACRIN MEDICAL RESEARCH FOUNDATION
|
|
Winship Cancer Institute, National Clinical Trials Network Lead Academic Particip
|
5U10CA180864-03
|
$542,807
|
$20,355
|
RAMALINGAM, SURESH
|
EMORY UNIVERSITY
|
|
IGF::OT::IGF OPTION 1: CORE INFRASTRUCTURE SUPPORT FOR SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) POP: 05/01/2016 - 04/30/2017
|
261201300015I
|
$2,313,271
|
$346,991
|
UNKNOWN, UNKNOWN
|
EMORY UNIVERSITY
|
|
Accelerated discovery of methylation targeted therapeutic development
|
1R43CA212733-01
|
$224,214
|
$112,107
|
SUN, ZU-WEN
|
EPICYPHER, INC.
|
|
Novel Approach to Facilitate Decisions in Patients w/ Muscle Invasive Bladder CA
|
5R21CA176551-02
|
$197,300
|
$197,300
|
DIEFENBACH, MICHAEL
|
FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
|
|
Hutchinson Center as Lead Academic Participating Site (U10)
|
5U10CA180828-03
|
$541,578
|
$27,079
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
CORE INFRASTRUCTURE SUPPORT FOR SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) OPTION 1.
|
261201300012I
|
$4,519,109
|
$677,866
|
UNKNOWN, UNKNOWN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
IGF::OF::IGF OPTION 1:CORE INFRASTRUCTURE SUPPORT FOR SURVEILLANCE, EPIDEMIOLOGY AND END RESULTS (SEER); PERIOD OF PERFORMANCE: 05/01/2016 TO 04/30/2017
|
261201300009I
|
$1,469,253
|
$220,388
|
UNKNOWN, UNKNOWN
|
HAWAII UNIV
|
|
Understanding barriers to single-dose intravesical chemotherapy in non-muscle invasive bladder cancer
|
1K23CA212272-01
|
$145,163
|
$145,163
|
CARY, KELLY
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
Total relevant funding to Bladder for this search: $33,995,868
|